Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Mitchell C. C. Liu · SciRah

Researcher profile · Semantic Scholar

Mitchell C. C. Liu

Share profile

Mitchell C. C. Liu — researcher profile on SciRah

h-index: 32
Works: 169
Citations: 5,659

Most-cited papers

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.
D. Palma, R. Olson, S. Harrow, S. Gaede +18 more
2019The Lancet1,448 citations
Semantic Scholar
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
D. Palma, R. Olson, S. Harrow, S. Gaede +20 more
2020medRxiv1,000 citations Open access
Semantic Scholar
Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial.
A. Sahgal, S. Myrehaug, S. Siva, G. Masucci +17 more
2021The Lancet Oncology320 citations
Semantic Scholar
Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial
D. Palma, R. Olson, S. Harrow, R. Correa +21 more
2019BMC Cancer219 citations Open access
Semantic Scholar
Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial
D. Palma, C. Haasbeek, G. Rodrigues, M. Dahele +9 more
2012BMC Cancer190 citations Open access
Semantic Scholar
Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET) - Extended Long-Term Outcomes.
S. Harrow, D. Palma, R. Olson, S. Gaede +18 more
2022International Journal of Radiation Oncology, Biology, Physics177 citations Open access
Semantic Scholar
Population‐based 10‐year oncologic outcomes after low‐dose‐rate brachytherapy for low‐risk and intermediate‐risk prostate cancer
W. Morris, M. Keyes, I. Spadinger, W. Kwan +5 more
2013Cancer119 citations
Semantic Scholar
Stereotactic ablative radiotherapy for the comprehensive treatment of 1–3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial
R. Olson, Lindsay Mathews, Mitchell C. C. Liu, D. Schellenberg +20 more
2020BMC Cancer105 citations Open access
Semantic Scholar
International consensus recommendations for target volume delineation specific to sacral metastases and spinal stereotactic body radiation therapy (SBRT).
E. Dunne, A. Sahgal, S. Lo, A. Bergman +10 more
2019Radiotherapy and Oncology81 citations
Semantic Scholar
Rectal toxicity and rectal dosimetry in low-dose-rate (125)I permanent prostate implants: a long-term study in 1006 patients.
M. Keyes, I. Spadinger, Mitchell C. C. Liu, T. Pickles +9 more
2012Brachytherapy69 citations
Semantic Scholar
The Impact of Peer Review of Volume Delineation in Stereotactic Body Radiation Therapy Planning for Primary Lung Cancer: A Multicenter Quality Assurance Study
A. Lo, Mitchell C. C. Liu, E. Chan, C. Lund +9 more
2014Journal of Thoracic Oncology61 citations Open access
Semantic Scholar
Treatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer: Primary Toxic Effect Results of the Nonrandomized Phase 2 SABR-5 Clinical Trial.
R. Olson, Will Jiang, Mitchell C. C. Liu, A. Bergman +24 more
2022JAMA Oncology60 citations Open access
Semantic Scholar
Quality of Life Outcomes after Stereotactic Ablative Radiotherapy (SABR) vs. Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized Trial.
R. Olson, S. Senan, S. Harrow, S. Gaede +18 more
2019International Journal of Radiation Oncology, Biology, Physics52 citations Open access
Semantic Scholar
Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases
R. Yeung, J. Hamm, Mitchell C. C. Liu, D. Schellenberg
2017Radiation Oncology37 citations Open access
Semantic Scholar
A three-isocenter jagged-junction IMRT approach for craniospinal irradiation without beam edge matching for field junctions.
F. Cao, R. Ramaseshan, R. Corns, S. Harrop +7 more
2012International Journal of Radiation Oncology, Biology, Physics36 citations
Semantic Scholar
Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer
C. Wujanto, B. Vellayappan, S. Siva, A. Louie +6 more
2019Frontiers in Oncology34 citations Open access
Semantic Scholar
Dose/volume-response relations for rectal morbidity using planned and simulated motion-inclusive dose distributions
M. Thor, A. Apte, J. Deasy, Å. Karlsdottir +3 more
2013Radiotherapy and Oncology34 citations Open access
Semantic Scholar
Stereotactic body radiation therapy for lung, spine and oligometastatic disease: current evidence and future directions.
E. Dunne, I. Fraser, Mitchell C. C. Liu
2018Annals of Translational Medicine32 citations Open access
Semantic Scholar
Outcomes of stereotactic body radiotherapy 60 Gy in 8 fractions when prioritizing organs at risk for central and ultracentral lung tumors
Yi-Zhou Zhao, Eman Khawandanh, S. Thomas, Susan Zhang +3 more
2020Radiation Oncology31 citations Open access
Semantic Scholar
The Vancouver rapid access clinic for palliative lung radiation, providing more than just rapid access
S. Lefresne, E. Berthelet, R. Cashman, Karen S Levy +5 more
2014Supportive Care in Cancer26 citations
Semantic Scholar
Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? A secondary analysis of the population-based phase II SABR-5 trial.
Reno Eufemon Cereno, B. Mou, S. Baker, N. Chng +26 more
2023Radiotherapy and Oncology24 citations
Semantic Scholar
Cross-modality applicability of rectal normal tissue complication probability models from photon- to proton-based radiotherapy.
J. Pedersen, S. Flampouri, C. Bryant, Xiao-Ying Liang +4 more
2019Radiotherapy and Oncology23 citations Open access
Semantic Scholar
Thecal Sac Contouring as a Surrogate for the Cauda Equina and Intra-Canal Spinal Nerve Roots for Spine Stereotactic Body Radiotherapy (SBRT): Contour Variability and Recommendations for Safe Practice.
E. Dunne, S. Lo, Mitchell C. C. Liu, A. Bergman +10 more
2021International Journal of Radiation Oncology, Biology, Physics21 citations
Semantic Scholar
Dose-distance metric that predicts late rectal bleeding in patients receiving radical prostate external-beam radiotherapy
Richard J. Lee, E. Chan, R. Kosztyla, Mitchell C. C. Liu +1 more
2012Physics in Medicine and Biology21 citations
Semantic Scholar
Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5
R. Olson, Mitchell C. C. Liu, A. Bergman, S. Lam +16 more
2018BMC Cancer17 citations Open access
Semantic Scholar
Re‐irradiation volumetric modulated arc therapy optimization based on cumulative biologically effective dose objectives
N. McVicar, S. Thomas, Mitchell C. C. Liu, H. Carolan +1 more
2018Journal of Applied Clinical Medical Physics16 citations Open access
Semantic Scholar
A randomized phase II/III study comparing stereotactic body radiotherapy (SBRT) versus conventional palliative radiotherapy (CRT) for patients with spinal metastases (NCT02512965).
A. Sahgal, S. Myrehaug, K. Dennis, Mitchell C. C. Liu +13 more
201713 citations
Semantic Scholar
Population-based validation of a policy change to use long-term androgen deprivation therapy for cT3-4 prostate cancer: impact of the EORTC22863 and RTOG 85-31 and 92-02 trials.
E. Tran, M. Paquette, T. Pickles, J. Jay +6 more
2013Radiotherapy and Oncology13 citations
Semantic Scholar
The TEACHH model to predict life expectancy in patients presenting for palliative spine radiotherapy: external validation and comparison with alternate models
M. Dosani, S. Tyldesley, B. Bakos, J. Hamm +5 more
2018Supportive Care in Cancer12 citations
Semantic Scholar
Prospective analysis of patient reported symptoms and quality of life in patients with incurable lung cancer treated in a rapid access clinic.
S. Lefresne, R. Olson, R. Cashman, P. Kostuik +7 more
2017Lung Cancer12 citations
Semantic Scholar
Biochemical control with radiotherapy improves overall survival in intermediate and high-risk prostate cancer patients who have an estimated 10-year overall survival of >90%.
C. Herbert, Mitchell C. C. Liu, S. Tyldesley, W. Morris +5 more
2012International Journal of Radiation Oncology, Biology, Physics12 citations
Semantic Scholar
A comparison of two disease burden assessment methods (3D volume versus the number of lesions) for prognostication of survival in metastatic melanoma: implications for the characterization of oligometastatic disease.
Jina Kim, Jee-Suk Chang, W. Sung, Jin Sung Kim +9 more
2022International Journal of Radiation Oncology, Biology, Physics10 citations Open access
Semantic Scholar
The Distribution and Patterns of Practice of Stereotactic Ablative Body Radiotherapy in Canada.
C. Lund, J. Cao, Mitchell C. C. Liu, R. Olson +2 more
2014Journal of Medical Imaging and Radiation Sciences10 citations
Semantic Scholar
Stereotactic Ablative Radiation Therapy for Colorectal Liver Metastases.
R. Mcdermott, E. Dunne, Y. Md, A. Bergman +3 more
2022Clinical colorectal cancer9 citations
Semantic Scholar
Comparison of 2-Weekly Versus 4-Weekly Durvalumab Consolidation for Locally Advanced NSCLC Treated With Chemoradiotherapy: A Brief Report
M. Denault, S. Kuang, A. Shokoohi, B. Leung +7 more
2022JTO Clinical and Research Reports9 citations Open access
Semantic Scholar
Implementation of Single-Fraction Lung Stereotactic Ablative Radiotherapy in a Multicenter Provincial Cancer Program During the COVID-19 Pandemic
B. Mou, D. Hyde, C. Araujo, L. Bartha +2 more
2021Cureus8 citations Open access
Semantic Scholar
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Randomized Trial
D. Palma, R. Olson, S. Harrow, S. Gaede +20 more
2020International Journal of Radiation Oncology, Biology, Physics7 citations
Semantic Scholar
Successful treatment of hepatic oligometastases with stereotactic ablative radiotherapy and radiofrequency ablation in an anaplastic lymphoma kinase fusion‐positive lung cancer patient
B. Weber, Mitchell C. C. Liu, Paul Sobkin, S. Morris +4 more
2015Journal of Medical Radiation Sciences7 citations Open access
Semantic Scholar
Influence of image slice thickness on rectal dose-response relationships following radiotherapy of prostate cancer
C. Olsson, M. Thor, Mitchell C. C. Liu, V. Moissenko +4 more
2014Physics in Medicine and Biology7 citations Open access
Semantic Scholar
Beyond PACIFIC: Real-World Outcomes of Adjuvant Durvalumab According to Treatment Received and PD-L1 Expression
M. Denault, Jamie Feng, S. Kuang, A. Shokoohi +8 more
2023Current Oncology5 citations Open access
Semantic Scholar
Four‐dimensional dose calculations for dynamic tumour tracking with a gimbal‐mounted linear accelerator
Emilie E. Carpentier, R. Mcdermott, E. Dunne, M. Camborde +5 more
2021Journal of Applied Clinical Medical Physics5 citations Open access
Semantic Scholar
A Kidney Conundrum: More or Less?
E. Dunne, Mitchell C. C. Liu
2019International Journal of Radiation Oncology, Biology, Physics5 citations
Semantic Scholar
8: Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-Comet Randomized Trial
D. Palma, R. Olson, S. Harrow, S. Gaede +20 more
2020Radiotherapy and Oncology4 citations Open access
Semantic Scholar
Prospective Analysis of Patient-Reported Symptoms and Quality of Life in Patients With Incurable Lung Cancer Treated in a Rapid Access Clinic
S. Lefresne, R. Olson, R. Cashman, Wei Jiang +6 more
20144 citations Open access
Semantic Scholar
Mathematical prediction with pretreatment growth rate of metastatic cancer on outcomes: implications for the characterization of oligometastatic disease
Yerim Shin, J. Chang, Yeseul Kim, S. Shin +6 more
2023Frontiers in Oncology3 citations Open access
Semantic Scholar
23: Cost-Effectiveness of Sabr in Oligometastatic Cancer: An Economic Analysis Based on Long-Term Results of the SABR-Comet Randomized Trial
M. Qu, Yu-Jie Chen, G. Zaric, S. Senan +14 more
2021Radiotherapy and Oncology3 citations
Semantic Scholar
Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of SABR-Comet
M. Qu, Yu-Jie Chen, G. Zaric, S. Senan +14 more
2019International Journal of Radiation Oncology, Biology, Physics3 citations
Semantic Scholar
Comparison of Rapid to Standard Volumetric Modulated Arc Therapy for Palliative Radiotherapy in Lung Cancer Patients
D. Mak, I. Fraser, R. Ferris, K. James +4 more
2020Cureus2 citations Open access
Semantic Scholar
1247P Uptake of durvalumab in the management of stage III NSCLC: The real-world application of PACIFIC
S. Kuang, Mitchell C. C. Liu, C. Ho, E. Berthelet +4 more
20202 citations Open access
Semantic Scholar
225 Dynamic Tumour Tracking (DTT) for Hepatocellular Carcinoma Using a Gimbaled Linac Stereotactic Body Radiation Therapy (SBRT) System
E. Dunne, A. Bergman, C. Rodgerson, M. Camborde +4 more
2019Radiotherapy and Oncology2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Schellenberg×19
Invite
D. Schellenberg — researcher profile on SciRah
R. Olson×17
Invite
R. Olson — researcher profile on SciRah
S. Gaede×11
Invite
S. Gaede — researcher profile on SciRah
D. Palma×10
Invite
D. Palma — researcher profile on SciRah

×10

Invite

S. Harrow — researcher profile on SciRah

Invite

A. Louie — researcher profile on SciRah

Invite

S. Senthi — researcher profile on SciRah

Invite

L. Mulroy — researcher profile on SciRah

A. Swaminath×9

Invite

A. Swaminath — researcher profile on SciRah

Invite

A. Warner — researcher profile on SciRah

Invite

A. Bergman — researcher profile on SciRah

Invite

C. Haasbeek — researcher profile on SciRah